Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PROCARBAZINE HYDROCHLORIDE
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma
- RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL
- A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
- Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)
- LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
- Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
- Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
- Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas
- BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
- Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System
- Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
- Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol
- HD21 for Advanced Stages
- Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
- Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
- Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD
- A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma
- Procarbazine and Lomustine in Recurrent Glioblastoma
- Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
- Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
- Prospective Study on HIV-related Hodgkin Lymphoma
- Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
- Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma
- Bevacizumab in Recurrent Grade II and III Glioma
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
- Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
- Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
- Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
- Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
- Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma
- Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
- Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
- A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
- Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
- Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
- Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
- Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
- Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
- Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
- Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
- Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
- Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
- Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
- HD12 for Advanced Stages
- HD11 for Intermediate Stages
- Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
- Study for Treatment of Cancer in Children With Ataxia-telangiectasia
- Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
- Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
- Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
- A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
- Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
- Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
- Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
- Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
- Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
- Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
- Procarbazine in Treating Patients With Recurrent Brain Tumor
- Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
- Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
- Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
- Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
- Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
- SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
- Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
- Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
- Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
- Combination Chemotherapy in Treating Children With Progressive Brain Tumors
- Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
- Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
- Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
- Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
- RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
Clinical trials list
click for details